Literature DB >> 34141088

Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.

Maho Takioku1, Yuta Takamura1, Michiko Fujihara1,2, Masaki Watanabe1, Shoya Yamada1,3, Mayu Kawasaki4, Sohei Ito4, Shogo Nakano4, Hiroki Kakuta1.   

Abstract

Retinoid X receptor (RXR) ligands often bind in modes in which the carboxy group forms a hydrogen bond inside the ligand-binding pocket (LBP). However, our previously reported RXR antagonist, CBTF-EE (4a), binds with its carboxy group directed outside the LBP and its alkoxy side chain located inside the LBP. Here, we examined the binding modes of 4b and 4c bearing a nitrobenzoxadiazole (NBD) or boron-dipyrromethene (BODIPY) fluorophore, respectively, at the end of the alkoxy chain of 4a. Both compounds function as RXR antagonists. 4c, but not 4b, was available for a fluorescence polarization binding assay, indicating that rotation of BODIPY, but not NBD, is restricted in the bound state. The fluorescence findings, supported by docking simulations, suggest the fluorophores are located outside the LBP, so that the binding mode of 4b and 4c is different from that of 4a. The assay results were highly correlated with those of a [3H]9-cis-retinoic acid assay.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 34141088      PMCID: PMC8201752          DOI: 10.1021/acsmedchemlett.1c00201

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  30 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Retinoid X receptor ligands: a patent review (2007 - 2013).

Authors:  Shoya Yamada; Hiroki Kakuta
Journal:  Expert Opin Ther Pat       Date:  2014-01-24       Impact factor: 6.674

3.  Retinoid X receptor-antagonistic diazepinylbenzoic acids.

Authors:  M Ebisawa; H Umemiya; K Ohta; H Fukasawa; E Kawachi; G Christoffel; H Gronemeyer; M Tsuji; Y Hashimoto; K Shudo; H Kagechika
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-12       Impact factor: 1.645

4.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.

Authors:  Yuchen Xia; Arnaud Carpentier; Xiaoming Cheng; Peter Daniel Block; Yao Zhao; Zhensheng Zhang; Ulrike Protzer; T Jake Liang
Journal:  J Hepatol       Date:  2016-10-14       Impact factor: 25.083

5.  Database of Absorption and Fluorescence Spectra of >300 Common Compounds for use in PhotochemCAD.

Authors:  Masahiko Taniguchi; Jonathan S Lindsey
Journal:  Photochem Photobiol       Date:  2018-02-13       Impact factor: 3.421

6.  Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

Authors:  B M Forman; K Umesono; J Chen; R M Evans
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

7.  The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.

Authors:  Yoshiteru Sato; Nick Ramalanjaona; Tiphaine Huet; Noelle Potier; Judit Osz; Pierre Antony; Carole Peluso-Iltis; Pierre Poussin-Courmontagne; Eric Ennifar; Yves Mély; Annick Dejaegere; Dino Moras; Natacha Rochel
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 8.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

9.  LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling.

Authors:  Kristine Y DeLeon-Pennell; Alan J Mouton; Osasere K Ero; Yonggang Ma; Rugmani Padmanabhan Iyer; Elizabeth R Flynn; Ingrid Espinoza; Solomon K Musani; Ramachandran S Vasan; Michael E Hall; Ervin R Fox; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2018-08-21       Impact factor: 17.165

10.  A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.

Authors:  Daisuke Morichika; Nobuaki Miyahara; Utako Fujii; Akihiko Taniguchi; Naohiro Oda; Satoru Senoo; Mikio Kataoka; Mitsune Tanimoto; Hiroki Kakuta; Katsuyuki Kiura; Yoshinobu Maeda; Arihiko Kanehiro
Journal:  Respir Res       Date:  2019-01-03
View more
  2 in total

1.  Increased Molecular Flexibility Widens the Gap between K i and K d values in Screening for Retinoid X Receptor Modulators.

Authors:  Masaki Watanabe; Mariko Nakamura-Nakayama; Michiko Fujihara; Mayu Kawasaki; Shogo Nakano; Hiroki Kakuta
Journal:  ACS Med Chem Lett       Date:  2022-01-21       Impact factor: 4.345

2.  Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo.

Authors:  Negar Khazan; Kyu Kwang Kim; Jeanne N Hansen; Niloy A Singh; Taylor Moore; Cameron W A Snyder; Ravina Pandita; Myla Strawderman; Michiko Fujihara; Yuta Takamura; Ye Jian; Nicholas Battaglia; Naohiro Yano; Yuki Teramoto; Leggy A Arnold; Russell Hopson; Keshav Kishor; Sneha Nayak; Debasmita Ojha; Ashoke Sharon; John M Ashton; Jian Wang; Michael T Milano; Hiroshi Miyamoto; David C Linehan; Scott A Gerber; Nada Kawar; Ajay P Singh; Erdem D Tabdanov; Nikolay V Dokholyan; Hiroki Kakuta; Peter W Jurutka; Nina F Schor; Rachael B Rowswell-Turner; Rakesh K Singh; Richard G Moore
Journal:  J Med Chem       Date:  2022-04-11       Impact factor: 8.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.